FDA Inspection
Continental Services Group, Inc.Continental Services Group, Inc. – FDA Inspection, Apr 30, 2026
Record Details
This FDA Inspection record concerns Continental Services Group, Inc., with an inspection on April 30, 2026, issued by the Florida District Office, covering biologics.
View Company Profile
ID · 55b9157e-b544-42f8-aae3-2c295c2fa1e3
Inspection Facts
- Inspection number
- 1314786
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.170(a)Adverse Reaction- Reports of Investigations
- 21 CFR 606.65Safe, sanitary, orderly storage
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Continental Services Group, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2024 | VAI | Florida District Office | Blood and Blood Products |
| August 24, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 31, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 1, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 27, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Continental Services Group, Inc.
- FDA Inspection 1244489 - 2024-07-24
- FDA Inspection 1178109 - 2022-08-24
- FDA Inspection 1091317 - 2019-05-31
- FDA Inspection 899467 - 2014-10-01
- FDA Inspection 850881 - 2013-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.